Fisher Scientific, part of Thermo Fisher Scientific Inc., today announced its new Life Technologies catalogue for Europe, which focuses on new products in application areas including cell culture, cloning and transformation, electrophoresis, PCR, purification and quantitation.
Fisher Scientific will distribute the new Life Technologies catalogue to customers in Belgium, Denmark, France, Norway, Spain, Sweden and the UK. It will include products from a range of brands including: Invitrogen®, Applied Biosystems®, Ambion®, Gibco®, Dynal®, Gateway®, Lipofectamine™, Novex®, Superscript® and TOPO®.
“This is a comprehensive technical catalogue that provides application-based solutions to our customers and supports them in their science,” said Rupa Ark, Sales Manager, Life Sciences, Fisher Scientific. “We’re pleased to launch the important resource just one month after Fisher Scientific received the prestigious European Life Technologies award.”
For more information on the Life Technologies catalogue contact email@example.com.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of nearly $11 billion, we have approximately 37,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications. Visit www.thermofisher.com.